Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2015

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	Three Months Ended September 30,
Medical Indication	2015		2014
Antibiotic	$	2,727	$	3,003
Cardiovascular	8,303		18,939
Gallstone	19,972		11,761
Glaucoma	6,822		4,691
Gout	64		2,299
Migraine	5,542		5,795
Muscle Relaxant	1,661		340
Obesity	979		915
Pain Management	8,133		6,655
Thyroid Deficiency	41,102		33,346
Other	11,128		5,643
Total	$	106,433	$	93,387

Summary of products which accounted for at least 10% of net sales

	2015		2014
Product 1	39	%	36	%
Product 2	19	%	13	%
Product 3	6	%	19	%

Summary of customers which accounted for at least 10% of net sales

	2015		2014
Customer A	28	%	31	%
Customer B	12	%	8	%
Customer C	8	%	9	%